Icariin from Epimedium: A Multi-Target Natural Flavonoid and Its Multi-Disease Therapeutic Potential.

Abstract

Icariin (ICA), an isoprenylated flavonoid glycoside extracted from the traditional Chinese herb Epimedium, is the primary bioactive constituent of that herb. ICA has been documented to have a diverse array of bioactivities which encompass anti-inflammatory and immunomodulatory effects, anti-oxidant stress resistance, anti-aging properties, antitumor activity, anti-osteoporotic effects, and reproductive function enhancement. ICA intervenes in basic processes such as cellular stress, inflammation, metabolism and death through multiple targets and pathways, and can restore the body's balance in specific pathological states. Building on these findings, this paper describes ICA's therapeutic efficacy across diverse pathologies, such as cancer, rheumatoid arthritis (RA), osteoarthritis, osteoporosis, gastrointestinal diseases, ischemic stroke, and neurodegenerative diseases, while elucidating its underlying molecular mechanisms. This study also explores new methods of preparing ICA with the goal of both expanding its therapeutic uses and supporting its clinical translation. However, the toxicological profile and clinical evidence for ICA are still not well understood, and thus, more research is needed before ICA can be confirmed as a viable treatment.